Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brussels South Biopark is a premier life sciences ecosystem located in Charleroi (Gosselies), Belgium, that serves as a major European hub for biotechnology and biomanufacturing. Established in 1999, the park hosts over 100 companies and research institutes, integrating academic excellence from the Université Libre de Bruxelles (ULB) and the University of Mons (UMONS) with industrial development. The ecosystem is particularly renowned for its concentration of cell and gene therapy manufacturing capacity, which accounts for approximately 20% of the total European capacity. Key residents include global leaders such as Thermo Fisher Scientific and Catalent, alongside innovative Belgian firms like iTeos Therapeutics and Univercells. The park provides comprehensive support through state-of-the-art incubators, specialized training facilities like the EU Biotech Campus, and a robust network of investors and partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brussels South Biopark.